IGF1 and colorectal carcinoma: As this study was carried out only in a male population, the researchers extended it to women with an increased risk of CRC and showed consistently that isoflavone administration did not significantly affect circulating levels of IGF system components or influence serum concentrations and tissue mRNA expression [42].